TSANZ home

Results for "tsanz lab"

Home 5 Search query for: tsanz lab
Results for "tsanz lab"

TSANZ Research Medal Presentations

TSANZ Research Medal Presentations

Date Recorded: 28th July 2020

Duration: Approx. 1 Hour

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

TSANZ Research Medal Winners 2020:

Professor Shyamali Dharmage

Title of talk:
Pre-COPD: where are we and where to from here?

BIO
Prof Dharmage has been formerly trained in Medicine, Public Health and Epidemiology. She conceived and developed the Melbourne University Allergy and Lung Health Unit that is at the forefront of the research into environmental and genetic risk factors for and biological pathways of chronic respiratory diseases. She is the PI of two of the world’s key longitudinal studies in lung health, the Tasmanian Longitudinal Health Study and the Melbourne Atopy Family Cohort Study. She is also the PI of the Australian Centre of RHINESA, a three generation international study of asthma and Australian Centre of Ageing Lungs in European Cohorts (ALEC). She has secured over 60 million Australian Dollars for her research program and published over 400 peer reviewed articles including in Lancet, Lancet Respiratory Medicine, Nature Genetics, American Journal of Respiratory and Critical Care Medicine, and BMJ. She has been on a number of editorial boards including her current positions in Clinical and Experimental Allergy and Lancet Respiratory Medicine. Her current interests include lifetime lung function and asthma trajectories and transgenerational risk factors for poor lung health.

Professor Alan James

Title of talk:
Defining Airway Disease Phenotypes for Clinical Use

BIO
Alan James is a consultant respiratory physician and clinical scientist at Sir Charles Gairdner Hospital, Hollywood Private Hospital and the University of Western Australia in Perth, Western Australia. He and his research team are studying mechanisms of excessive airway narrowing in asthma, particularly the roles of increased smooth muscle and matrix and how to measure them, with a view to new treatments. As Chair of the Busselton Health Study he also leads research teams studying healthy ageing and the characteristics of airway disease such as asthma, cough, COPD, airway inflammation and altered airway structure in the general population. These studies aim to improve appropriate management of airway diseases at the primary care level. He has published over 250 journal articles, book chapters and editorials and in 2017 received the Asia Pacific Society of Respirology Ann Woolcock Research Medal.

Registration:

To register your interest in the on-demand recording, please register below. You will then be sent an e-mail, allowing you to obtain the recording links through Vimeo.

Category Fee (excl. GST)
TSANZ Members Free
Non-members $20

Require assistance?

Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

TSANZ Ann Woolcock New Investigator Award Session

TSANZ Ann Woolcock New Investigator Award Session

Date Recorded: 23rd May 2020

Duration: Approx. 2hrs

The Ann Woolcock New Investigator Session is usually presented at the TSANZ Annual Scientific Meeting to acknowledge excellence in the conduct and presentation of scientific research. This year finalists will make their presentations online, with the session chaired by Sandra Hodge and Kristin Carson-Chahhoud.

Each presentation will be of ten minutes in length followed by five minutes for questions.

Members of the TSANZ Research Sub-Committee and invited experts will judge the presentations using the following criteria: Scientific Quality (50%), Standard of Presentation and Communication (30%), Responses to Questions (20%).

Chairs: Professor Sandra Hodge and Associate Professor Kristin Carson-Chahhoud

Finalists Presentation
Kak-Ming Ling, Luke Garratt, Erin Gill, Amy Lee, Patricia Agudel-Romero, Erika Sutanto, Thomas Iosifidis, Stuart Turvey, Brian Button, David Thornton, Timo Lassmann, Robert Hancock, Anthony Kicic, Stephen Stick Augmented Airway Epithelial Responses to Rhinovirus in Children with Cystic Fibrosis (CF)
Rebecca Stockell, Lex, Leong, Nicole Wheeler, Josephine Bryant, Michelle Wood, Laura Sherrard, Rachel Thomson, Robyn Carter, Carla Tolson, Geraint Rogers, Claire Wainwright, Julian Parkhill, R.Andres Floto, Scott Bell Alternative transmission pathways of Mycobacterium abscessus group (MABS) respiratory infections
Steven Taylor, Lex Leong, Kerry Ivey, Steve Wesselingh, Keith Grimwood, Claire Wainwright, Geraint Rogers Understanding paediatric cystic fibrosis lung infections: What should we be measuring?
Pamela Laird, Mary Lane, Roz Walker, Anne Chang, André Schultz Culturally informed healthcare transforms lung health for Aboriginal children
Kurtis Budden, Saima Firdous Rehman, Shakti Shukla, Kate Bowerman, Chantal Donovan, Henry Gomez, Priyanka Sahu, Charlotte Alemao, Andrew Holmes, Paul Dennis, Philip Hugenholtz, Peter Wark, Philip Hansbro Diet influences COPD pathogenesis by regulating microbial metabolism
Razia Zakarya, Yik L Chang, Hui Chen, Corry-Anke Brandsma, Ian Adcock, Brian Oliver BET protein propagated histone acetylation mediates small airway fibrosis in COPD

Registration:

Category Fee (excl. GST)
TSANZ Members Free
Non-members $20

.

Require assistance?

Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

VOLUME 2.6 AUGUST 2017

VOLUME 2.6 AUGUST 2017

Research Roundup:

August  2017

.
 

Welcome Message

Have you heard? Abstracts for TSANZSRS 2018 are now open. With this, our abstract-linked awards are also open. We are once again calling for applicants for the Ann Woolcock New Investigator Award, the JRS Travel Award, the Janet Elder Travel Award, and the Boehringer Ingelheim COPD Travel Award – which is now available to support travel to a range of international respiratory conferences (instead of only CHEST). Our ASM Travel awards are also open and we hope that everyone who is eligible takes up these opportunities.

More details on these awards are below and online.

Just over the horizon is APSR 2017 in Sydney.  A large number of abstracts have been received and late breaking abstracts will open on August 9th. Abstract acceptance will be notified in mid- August. If your abstract is accepted, you must be registered by September 28th. The developing program is now live. The theme is Lung Health in a Changing Worldand with a diverse and experienced group of international speakers attending, this should be a highly educational and engaging meeting. Early bird registration closes 3 September.

We have been able to partner with TEVA Pharmaceuticals and launch the TSANZ/TEVA Scholar Awards which cover registration costs for APSR 2017. These are open to Advanced Trainees in Respiratory and/or Sleep medicine and applications close on the 30th of August. Please spread the word – there are 30 scholarships available.

I would also like to update you on the consultation on A framework for NHMRC assessment and finding of clinical trials and cohort studies which we recently responded to. Thank you to those who assisted with this. Our response was in line with our commitment to increasing investment in respiratory research. While TSANZ was broadly supportive of the consultation recommendations, we advocated for inclusion of a policy review period, a moderation of process, opportunity to appeal and some consideration of a change in the length of the application given the necessity to include other supporting documentation for specific types of studies.

We will continue to work to increase funding for respiratory research and will adapt as the research landscape in Australia and New Zealand continues to change.

Lastly, there are a number of surveys at the end of this email and I urge you to participate in these and help where you can.

Enjoy the August edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

 

The following articles will take you to thelimbic.com

Work-related lung disease cases “tip of the iceberg”. A national register to record every case of work-related lung disease is one step closer following lobbying from the TSANZ and the Lung Foundation. Read More.

 + The rules for work-related lung disease compo are “unfair”. There are calls to expand the list of work-related lung disorders eligible for government compensation in NSW, amid concerns many with life-threatening conditions are missing out. Read More.

Oxygen saturation should be the 5th vital sign. A pulse oximeter should be as ubiquitous as a stethoscope, according to the British Thoracic Society’s new guidelines. Read More.

Non-invasive ventilation cuts COPD readmissions. Hard to treat patients with frequent COPD exacerbations can be kept out of hospital for longer when NIV is added to home oxygen. Read More.

Chronic breathlessness syndrome: a new name without shame.  We speak to Palliative medicine specialist Professor David Currow about his mission to get chronic breathlessness recognised as a distinct clinical entity. Read More.

Turf war stalling antibiotic stewardship. A rift between respiratory physicians and infectious diseases specialists could be stalling efforts to fight the growing problem of antimicrobial resistance in patients with respiratory infections, researchers claim. Read More.

Better bedside management of pleural effusions. Brisbane doctors have significantly improved the outcomes of patients with pleural effusions by giving registrars and trainees practical hands on training on the use of pleural ultrasound. Read More.

Open Awards

Thoracic Society Awards

TSANZ / TEVA Scholar Award

Encouraging all TSANZ Advanced Trainees Members to attend APSR 2017 for career development. Close 30 August 2017.

Abstract-linked awards are now open

Ann Woolcock New Investigator Award

The Ann Woolcock New Investigator Award is presented at the TSANZ Annual Scientific Meeting (ASM) to acknowledge excellence in the conduct and presentation of scientific research. 

This is a Travelling Fellowship of AUD$1500 plus expenses (return economy airfare, meeting registration and accommodation) to support the recipient to attend and present their original high-quality research to the next Annual Scientific Meeting of the Asia-Pacific Society of Respirology (APSR). Finalists (excluding the winning applicant) will receive a certificate of achievement and AUD $500.

This award furthers one of Professor Ann Woolcock’s goals of fostering research ties between the TSANZ and the APSR.

To apply for the Ann Woolcock New Investigator Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Ann Woolcock New Investigator Award eligibility criteria and application here coversheet please click here.

Boehringer Ingelheim COPD Travel Award

This travel award is designed to reward, encourage and provide international exposure for Advanced Trainees in Respiratory Medicine, junior Respiratory Physicians, post-doctoral respiratory healthcare professionals, and Respiratory Researchers whose work focuses on chronic obstructive pulmonary disease (COPD).

The award consists of up to AU$4000 to cover the recipient’s expenses (return airfare, registration, accommodation, living expenses) to attend and present an abstract at a relevant international respiratory conference, including: the American College of Chest Physicians, the European Respiratory Society, Asian Pacific Society of Respirology , or the American Thoracic Society.

To view the Boehringer Ingelheim COPD Travel Award eligibility criteria and application coversheet please click here.

Janet Elder International Travel Award

These awards will be made to three respiratory scientists or clinicians on the basis of scientific merit of their submitted abstract to the 2018 TSANZ Annual Scientific Meeting (ASM) to support their professional development in respiratory research. There will be two awards for early career researchers and one award for a mid-career researcher.

Each award consists of AUD$2500 to contribute to expenses to attend and present an abstract at an international scientific meeting of the recipient’s choice within the following year. 

These awards are made in the memory of Dr Janet Elder, one of the pioneers of respiratory medicine in Western Australia.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Janet Elder International Travel Award eligibility criteria and application coversheet please click here.

Japanese Respiratory Society (JRS) Early Career Development

This Early Career Development Award is designed to reward, encourage and provide international exposure to promising recent advanced trainees/higher degree graduates. 

The award will cover the recipient’s expenses (return economy airfare to Japan, registration, accommodation, living expenses) to attend and present at the Annual Scientific Meeting of the Japanese Respiratory Society in the following year. This award is fully provided by the Japanese Respiratory Society.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Japanese Respiratory Society (JRS) Early Career Development eligibility criteria and application coversheet please click here.

TSANZ Travel Grants to 2018 ASM

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the Annual Scientific Meeting (ASM) through presentation of their work and active participation in the meeting. They are awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields, based on the quality of the abstract submitted for presentation to the ASM.

To be eligible for the TSANZ Travel Grants to 2018 ASM Award, you must submit an accompanying form of certification (attach here) completed by your supervisor/head of department using the upload functionality in the online abstract submission form. To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the TSANZ Travel Grants to 2018 ASM eligibility criteria and application coversheet please click here.

Lung Foundation Australia Awards

Lung Foundation Australia and Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Research Fellowship – 2018/2019

Valued at $80,000 per year/ one or two years

Lung Foundation Australia / Boehringer Ingelheim COPD Fellowship supports research to improve the diagnosis and management of Chronic Obstructive Pulmonary Disease in Australia. Specifically, the proposed research must be aimed at developing and/or delivering optimal care to people with COPD.

Relevant domains of research inquiry range from evaluation of population screening initiatives; interventions to improve diagnostic accuracy within primary care; through to issues of management in the context of a clinician-patient interaction to system level issues to do with the organisation, financing and performance of the health system, including COPD management of indigenous and ethnic minorities within Australia.

Lung Foundation Australia invites applications from medical and scientific graduates who will be a resident in Australia throughout the period of the research program. The Fellowship is available as either a one or two year award, with a value of $A80,000 per annum. The funds are to cover the salary (including on-costs) for the successful research fellow and for no other purpose.

Apply now


NEW Lung Foundation Australia and the Better Breathing Foundation Allied Health PhD Scholarship in Chronic Lung Disease – 2018/2021

Valued at $20,000 per year/four years: $40,000 per year/four years with matched funds

This Scholarship is made possible via a collaborative partnership with Lung Foundation Australia and the Better Breathing Foundation. The LFA/BBF Allied Health PhD Scholarship aims to support allied health professionals to undertake research into chronic lung disease. Relevant domains of research include any form of clinical, population, laboratory or genetics research.

Students with an allied health background wishing to undertake a PhD in chronic lung disease are invited to submit an application. This PhD Scholarship is aimed at a researcher who is commencing a higher degree and interested in improving outcomes for patients living with a chronic lung disease.

Lung Foundation Australia/Better Breathing Foundation will be allocating a set amount of funds of $20,000 per year over a four year period (total funding: $80,000) for the PhD Scholarship, with matching funds to be provided by the University.

Apply now


Lung Foundation Australia / Ivan Cash Research Grant-in-Aid for Idiopathic Pulmonary Fibrosis Research 2018

Valued at $5,000

The Ivan Cash Research Grant-in-Aid’s creation was made possible by a bequest from Mr Ivan Cash, who sadly died from his idiopathic pulmonary fibrosis (IPF) in 2008. Lung Foundation Australia invites applications for the Ivan Cash Research Grant-in-Aid valued at $5,000. This IPF Research Award is open to any individual health care professional or scientist, who will be required to collaborate with the Australian IPF Registry management committee to undertake and publish a specific focused analysis of part of the collected dataset of the Australian IPF Registry. The Australian IPF Registry management committee will provide support to the successful applicant to enable the completion of the required research.

Apply now


Lung Foundation Australia / Lizotte Family Research Award for Interstitial Pulmonary Fibrosis Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Lizotte Family Research Award valued at $5,000 – to assist research in interstitial pulmonary fibrosis (IPF). This Research Award is open to any individual health care professional or group of health care professionals who are able to demonstrate an interest in IPF, including respiratory physicians, histopathologists, radiologists, researchers, registrars, trainees, nursing and allied health staff.

The funds may be used as a contribution towards IPF related research or pilot projects, or to fund travel or education with respect to increasing knowledge about IPF.

Apply now


Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Ludwig Engel Grant-in-Aid valued at $5,000 – to assist research in respiratory physiology. For the purpose of this Grant-in-Aid, Physiological Research is the use of any methodologies directed towards the elucidation of organ function and its understanding in a precise, quantitative manner.

The funds may be used as a contribution towards equipment, personnel or other running costs incurred in the conduct of research projects. The Grant-in-Aid is not to be used to fund conference travel or conference attendance.

Apply Now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to key health professionals in Australia whose work is focused on improving outcomes for patients living with COPD.

Apply now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

How to participate

Follow the links above to access each award application form and download the information sheet.

More Information

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Lung Foundation Australia contact details
Glenda Colburn | Phone 07 3251 3600 | Email: glenda@lungfoundation.com.au

Watch this space for more award announcements…

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late August and December, 2017:

Westpac Bicentennial Foundation Research Fellowship – closes 31/08/17
The Westpac Research Fellowship supports outstanding early career researchers whose ground-breaking work has the potential to make a difference in one of the Foundation’s focus areas: Technology and innovation, Strengthening Australia-Asia ties, and Enabling positive social change.

Westpac Bicentennial Foundation Social Change Fellowship – closes mid-August/2017
The Westpac Social Change Fellowship is an opportunity to invest in your capability, knowledge and networks with a view to helping you bring to life your innovative initiative for positive social change in Australia.

Rebecca L Cooper Medical Research Foundation – Medical Research Grants – closes 01/09/17
Advancing, promoting and encouraging medical research into Brain Sciences (psychiatry and neurology), Endocrinology and Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, Vision Sciences. Funding is primarily granted for the purchase of equipment, but may be used for other tangibles (e.g. therapeutic or imaging markers, software etc.). Funding requests for salaries/wages are not strongly supported, but will be considered by the directors.

The Prince Charles Hospital Foundation Emerging Researcher Grant – closes 01/09/17
The Emerging Researcher Grant is aimed at providing New Investigators who have previously received and successfully completed a New Investigator grant from TPCHF the opportunity to further develop their skills, experience and build the research capacity of TPCH The priority areas are: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Harkness Fellowships in Health Care Policy and Practice 2018-2019 – closes 05/09/17
For mid-career professionals (academic researchers, government policymakers, clinicians, managers, and journalists) from Australia, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom, to spend up to 12 months in the US conducting a policy-oriented research study, working with leading US health policy experts, and gaining an in-depth knowledge of the US and other health care systems.

Tasmania Community Fund – small grants close 06/09/17, large grants close 27/09/17
To fund community organisations that make a difference by enhancing well-being and improving the social, environmental and economic outcomes for the Tasmanian community. Five category areas: children and young people; community participation and recreation; community well-being and life skills; connecting communities; culture, arts and heritage. Large grants are for applications for large infrastructure, asset and/or equipment.

Future Research Leader Fellowships – EOI closes 15/09/17
5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to develop a program of work that support the activities that are being undertaken by the Translational Cancer Research Centres (TCRCs) in NSW. Applications must be in the area of implementation research and, more specifically, should address how research findings from the TCRCs can be taken up into routine cancer care.

CASS Medicine/Science Grants – 15/09/17
Research and development projects in science and/or medicine. Preference is given to proof of concept project applications. CASS will only accept applications from applicants employed by specific Victorian research centres.

Shepherd Foundation – closes 15/09/17
The Shepherd Foundation Trust welcomes grant applications from Victorian health professionals or research teams working in clinical, medical or scientific fields.  Grants are provided for research projects in all aspects of preventive medicine and/or occupational medicine. For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Conquer Cancer Career Development Award – closes 21/09/17
Provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Submissions in all oncology sub specialties are welcome.

Financial Markets Foundation for Children – closes 30/09/17
Research programs designed to improve the health, welfare and wellbeing of Australian children. Preference will be given to projects focussed on children aged 14 years and under, although the Foundation will consider projects relating to children up to 18 years of age.

Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/10/17
Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

World Cancer Research Fund International – closes 06/10/17
To fund research studies exploring the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival. There are 2 types of grants: Investigator Initiated Grants for Principal Investigators; and Pilot Grants to be used as start-up funds for pilot research. Two main themes: identifying the mechanisms that underpin the effects of diet, nutrition and physical activity on cancer; addressing the host factors that influence an individual’s susceptibility to cancer development or progression.

The Bonser Family Research Grant and Mi-tec Publishing Medical Research Grant – closes 21/10/17
Cancer Council Tasmania calling for research relating to the reduction of the incidence and impact of cancer on individuals and the community. It includes every aspect of care, from prevention and early detection that leads to a better outcome, treatment and supportive care. The priority area is cancer control.

Rolling Grants

Auswide Community Grants Scheme –  grants under $5 000 close 30/09/17, grants over $10 000 close 21/10/17, grants over$ 5 000 close 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

allport bequest – closes 30/06 and 31/12 yearly
Must benefit citizens of Hobart. Organisation must be charitable or the project must be for charitable purposes.

 

Respirology

New from ANZSRS

ANZSRS’s Spirometry Training Courses Position Statement
Maureen P. Swanney, Christopher A. O’Dea, Emily R. Ingram, Leanne T. Rodwell, Brigitte M. Borg, for the ANZSRS Spirometry Training Course Working Group

Respirology Issue 22.6

Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapores perspective on a global model.

HAI V. NGUYEN , SAIDEEP BOSE, SHWETA MITAL, ANTHONY CHAU ANG YII, SHIN YUH ANG, SEAN SHAO WEI LAM, DEVANAND ANANTHAM, ERIC FINKELSTEIN and MARIKO SIYUE KOH

DOI: 10.1111/resp.13027

 

Cost-effectiveness acceptability curve of bronchial thermoplasty with and without optimized asthma therapy

Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions

JONATHAN A. GALLI , ALOKNATH PANDYA, MICHELLE VEGA-OLIVO, CHANDRA DASS, HUAQING ZHAO and GERARD J. CRINER

DOI: 10.1111/resp.13024

Research team at the Temple Lung Center in Philadelphia, USA. From left to right: Huaqing Zhao, Jonathan Galli, Chandra Dass, Michelle Olivo-Vega and Gerard Criner.  Not included in the photo is Aloknath Pandya.

Research Project and Survey Requests

Inhaler Overhaul in Sight for Mild Asthma  –  recruitment closing soon

Friends and family with mild asthma could soon have a new treatment at their fingertips if results of the Novel Start Study show the condition can be well managed without daily medication.

People with apparently mild asthma make up 20 per cent of adults who die of asthma, and a third of people who need emergency asthma treatment,” says asthma specialist Professor Helen Reddel, who is heading the study in Australia.

Asthma experts in New Zealand and at the Woolcock Institute of Medical Research in Sydney and John Hunter Hospital in Newcastle are testing a new combination puffer treatment that could reduce asthma flare-ups and change the way mild asthma is treated worldwide.

Anyone who is using only Ventolin (or similar) for their asthma can volunteer – recruitment closes soon – by the end of August 2017.

Woolcock Institute, Sydney, Australia
Call: 02 9114 0444 or email gloria.foxley@sydney.edu.au

Hunter Medical Research Institute, Newcastle, Australia
Call: 02 4042 0532 or email joanne.howes@newcastle.edu.au

Medical Research Institute of NZ – Wellington, NZ
Call: 04 805 0147 or email irene.braithwaite@mrinz.ac.nz

 

 

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

ATS Conference Review

Please CLICK HERE to view the publication by Research Review on the recent American Thoracic Society (ATS) conference.

TSANZ Recruiting Now

Administrative Officer (up to $60,000 + super)

  • Excellent working conditions
  • Access to salary sacrifice and other benefits
  • Annual leave loading
  • Flexible working conditions, friendly team and great working environment

Function: This position is responsible for providing administrative support

Reports to: Chief Executive Officer (CEO)           

Salary: $50,000-$60,000 (dependent on experience)

Permanent full time

ROLE PURPOSE: This position is responsible for providing administrative support to the New Zealand Branch, assisting the CEO in managing the activities of the office and supporting the laboratory accreditation program.

Job Accountabilities:

  1. Document management is maintained for all TSANZ controlled documents
  2. Provides a high level of administrative support to the TSANZ Board and CEO
  3. Executive officer assistance to NZ branch to support compliance with NZ legislation and constitution
  4. Undertake administrative support to the laboratory accreditation program:
  • Provide administrative support to subcommittees
  • Regular liaison with the Laboratory Accreditation Coordinator and Subcommittee Chairs to ensure effective overall management of the laboratory accreditation program
  • Check the accreditation applications against TSANZ Laboratory Manual and communicate it back to the laboratories for any major inaccuracy
  • Organise laboratory site visit including date, agenda, travel and accommodation
  • Liaise with assessor panels and laboratories on an ongoing basis to make sure they have the information and support to provide the appropriate application and  assessment
  • Ensure reports/responses from assessor panels and laboratories are received on time, and provided to the CEO and Chair LAC for moderation
  • Maintain accreditation documents including the manual, forms and other templates
  • Maintain accreditation files of each laboratory to reflect best practice in document management
  • Maintain the accredited laboratory information on the TSANZ website
  • Preparation of reports and correspondence     

KEY SELECTION CRITERIA – please address the following in your application:

  • Experience in working in an office environment
  • Must have the ability to communicate accurately and clearly both orally and in writing
  • Pleasant telephone manner
  • Able to think on feet when dealing with callers
  • Customer service oriented with a “can do” approach to work
  • Microsoft Office expertise
  • A team player who is able to work effectively as part of a small productive team and as a self-motivated individual
  • Superior organisational skills, attention to detail and problem solving skills
  • Excellent people skills
  • Experience working in a quality assured environment is advantageous

HOW TO APPLY:

Click apply or send your resume to Tanya.Buchanan@thoracic.org.au by Friday 11th August 2017

Please clearly indicate your relevant experiences and skills to this role.

Position Description: https://www.thoracic.org.au/documents/item/1044

OVERVIEW OF TSANZ: The Thoracic Society of Australia and New Zealand Ltd (TSANZ) is a company limited by guarantee and a health promotion charity (HPC) established to improve the knowledge and understanding of lung disease, to prevent respiratory illness through research and health promotion, and improving health care for people with respiratory disorders.

For details concerning this role, please contact Tanya Buchanan, Phone : 0292226205
Email : tanya.buchanan@thoracic.org.au

You must have the right to live and work in this location to apply for this job.

 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 2.6 AUGUST 2017

VOLUME 7.06 – JULY 2022

Research Roundup:

July 2022

Welcome Message

Welcome to another issue of Research Roundup. Best of luck to everyone who applied for the recent Medical Research Future Fund grants. I hope you have all caught up on some sleep by now!

Speaking of grants there is a whole host of opportunities listed in this newsletter and quite a few are closing soon. TSANZ has two travel grants closing at the start of August, one for the inaugural TSANZSRS Education Hub, and one for the TSANZSRS NZ Branch ASM. Speaking of the NZ Branch ASM, their new investigator award closes on the 14th of August. Outside of TSANZ Cure4CF’s Holckner Family CF Impact Grant is offering up to $500,000 for Cystic Fibrosis research and this grant closes on the 5th of August. For those working outside of research ELF has grants of up to €1,000 for not-for-profit organisations, patient groups and healthcare professionals closing very soon, on the 31st of July.

In addition, the TSANZSRS ASM abstract linked awards have just opened! Details for these awards are outlined below. In related and exciting news, the value of both the Ann Woolcock New Investigator Award and Janet Elder International Travel Awards have increased to $5k each. A lot of the abstract linked awards are targeted to early-mid career researchers. If you fit into this category and have been thinking about submitting an abstract to TSANZ, you should absolutely consider extending your application to go for one, or even both of these awards at the same time. It may just be the steppingstone that takes you that little bit further along your career path.

The Limbic, Respirology and Respiratory Research Review have some excellent reads, and if you’re after further educational opportunities there are some interesting webinars across the next week. RACP are running a COVID webinar series in July, there’s one more session you can catch on the 28th; “COVID-19: Where to now?”. Next month on the 3rd of August ACTnet running a seminar on TB genomics.

Finally, if you ever find yourself feeling a little deprived of motivation, I strongly suggest a google search for Admiral McRaven’s 2014 commencement speech. He outlines 10 life lessons from his time as a navy seal…no wait, don’t stop reading yet. Seriously. I now have each of these printed on 10 A4 pieces of paper on the wall in my office. He has been and continues to be a source of inspiration for me, and for those of you who may be looking for that little push to open your next grant application template, this may be the productive procrastination activity for you.

As always, happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

TSANZSRS NZ Branch Meeting 2022 New Investigator Award – Abstract Submissions close 14th August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

TSANZSRS Annual Scientific Meeting 2023

Call for Abstracts

On behalf of the Organising Committees, we warmly invite you to attend the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand. The TSANZSRS 2023 meeting will be held at Te Pae Christchurch Convention Centre from 25th – 28th March 2023 with opportunities to attend pre-conference Postgraduate Courses on Friday 24th March.

TSANZ abstract awards are now open!

For more information regarding the TSANZSRS 2023 ASM and how to apply for the above awards visit https://www.tsanzsrsasm.com/

 

TSANZ Surveys

Help us improve our educational offerings to members and our skill base by completing the below surveys!

TSANZ Methodology Survey

Evidence-based practice skills among members of the TSANZ

The TSANZ is conducting this voluntary survey to identify members who have specific evidence-based practice (EBP) methodology skills to support the production of position statements and clinical practice guidelines by the Society.

We are asking you to fill out a questionnaire, which should take approximately 15 minutes to complete.

The study gives you an opportunity to tell us about:

  • The skills you have to perform specific elements of a systematic review for the development of Society documents
  • Your interest to learn/improve specific skills or share/teach specific skills

Survey link: https://forms.office.com/r/W6SUisW70g

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Education Hub Logo

Education Hub Travel Grants

The TSANZ and ANZSRS have established a scheme to assist early-career members to attend the TSANZSRS Education Hub. This is to encourage active participation in the Hub and will be awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields.

The travel grant for the 2022 TSANZSRS Education Hub will be to contribute to travel costs to maximum of AU$250*
* based on individual travel requirements with submitted evidence of costs.

Please click here for more information on the travel grant guidelines and eligibility criteria!

Please click here to register for the TSANZSRS Education Hub!

Respirology – Editor’s Choice

Respirology Issue 27.8 August 2022

Inhalational Exposures in Patients with Fibrotic Interstitial Lung Disease: Presentation, Pulmonary Function, and Survival in the Canadian Registry for Pulmonary Fibrosis

Cathryn T. Lee,Mary E. Strek,Ayodeji Adegunsoye,Alyson W. Wong,Deborah Assayag,Gerard Cox,Charlene D. Fell,Jolene H. Fisher,Andrea S. Gershon,Andrew J. Halayko,Nathan Hambly,Nasreen Khalil,Martin Kolb,Stacey D. Lok,Hélène Manganas,Veronica Marcoux,Julie Morisset,Mohsen Sadatsafavi,Shane Shapera,Teresa To,Pearce Wilcox,Christopher J. Ryerson,Kerri A. Johannson

DOI: 10.1111/resp.14267

 

External Grant Opportunities

European Lung Foundation Healthy Lungs for Life Grants

European Lung Foundation (ELF) is offering grants to support Healthy Lungs for Life activities.

Not-for-profit organisations, patient groups and healthcare professionals can apply for a grant of up to €1,000 to support events and activities that meet one or more of the aims of the Healthy Lungs for Life campaign:

Increase knowledge of the impact of poor air quality on lung health and the actions that everyone can take to reduce air pollution and avoid exposure
Highlight the benefits of quitting smoking
Increase knowledge of the importance of physical activity for lung health
Raise awareness of vaccination to prevent lung infections
This year we also strongly welcome applications linked to the topic of climate change and lung health.

Applications are now open for events focused on World Lung Day and awareness days later in 2022. The closing date for applications is 31 July 2022. To find out more and apply please follow this link.

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

Perspectives on Telehealth for the care of patients with Interstitial Lung Disease (ILD)

We are recruiting health professionals who are involved in the care of patients with Interstitial lung disease (ILD) to participate in this research project. Telehealth for ILD provides an opportunity to improve access to healthcare for patients. Its use has rapidly increased during the COVID-19 pandemic, however there is still a high level of dissatisfaction with telehealth amongst both patients with ILD and healthcare professionals. This study will help us to understand the opinions and experiences of patients with ILD, their caregivers and health professionals of using telehealth in the management of ILD, and ways in which the model can be improved.

Participation in the study will involve taking part in one interview, either in person, over the phone or via zoom. If you are interested in participating or would like further information on this study, please contact:
Dr Sheetal Deshpande
Phone: 03 9903 0214
Email: sheetal.deshpande1@monash.edu

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

Climate Change and Health – WA Healthcare Professionals Survey

The University of Western Australia and Department of Health WA are interested in your views on climate change and health. The information gathered through this project will be used to develop public health messaging and resources for both community and health professionals.

All WA healthcare professionals and healthcare workers with direct client or patient care contact are encouraged to participate. The survey is open from 18 July 2022 to 15 August 2022 and can be accessed online at https://consultation.health.wa.gov.au/pahd-sdu/climate-change-and-health/, and will take approximately fifteen minutes to complete.

Queries can be directed to Sarah Joyce at the Western Australia Department of Health, via email at sarah.joyce@health.wa.gov.au, or by phone on (08) 9222 4017.

LFA COVID-19 Survey

Lung Foundation Australia (LFA) are currently running a survey to gain an understanding of how COVID-19 has impacted Australians and what healthcare, information and support may be needed to help people manage ongoing symptoms. If you’ve had COVID-19 or cared for someone who has, LFA would love to hear your experience by completing this 5-10 minute survey. Completing the survey will put you in the running to win a $150 Visa gift card!

Even if you haven’t had COVID-19, you can share your experience on the government response during the pandemic and the impact of the pandemic on your access to healthcare.

Webinars and Seminars

RACP COVID-19

The RACP COVID-19 Expert Reference Group invites you to attend the upcoming July COVID webinar series.

The RACP have hosted a number of COVID-19 webinar series over the past couple of years in order to inform doctors about important COVID-19 matters, discuss key information and share learnings. We have a great line-up of panellists detailed below and are looking forward to some really engaging discussions.

Please register via the link to attend: REGISTRATION LINK

CALL FOR WEBINAR QUESTIONS – 28 JULY

Do you have any burning questions that you would like us to ask at the webinars? Please send them through to COVIDERG@racp.edu.au.

COVID-19: Where to now?

Thursday 28 July, 6pm-7.30pm AEST / 8pm-9.30pm NZST

This webinar will provide attendees with an understanding of some of the lessons learned though the COVID-19 pandemic and how they might be applied moving forward. The webinar will be in the format of an open panel discussion to guided questions as well as Q&A from webinar attendees.

Hosted by:
Dr Susan Graham, rehabilitation physician and Chair of the RACP COVID-19 Expert Reference Group
Associate Professor Asha Bowen, Head, Skin Health Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute and member of the RACP COVID-19 Expert Reference Group

Expert panellists include:
Professor Paul Kelly, Chief Medical Officer, Department of Health
Professor Christopher Blyth, Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Paediatric Infectious Diseases Physician and Clinical Microbiologist
Professor John Massie, Respiratory Physician and Clinical Director, Children’s Bioethics Centre, Royal Children’s Hospital
Dr Paresh Dawda, General Practitioner, Director and Principal Prestantia Health and Next Practice Canberra
Helen Kulas, NSW Respiratory Network Manager
Professor Peter Wark, Senior Staff Specialist – Respiratory and Sleep Medicine, John Hunter Hospital; Co-Chair NSW Respiratory Network

ACTnet TB Genomics Seminar

Whole genome sequencing of Mycobacterium tuberculsosis is increasingly being
implemented for antimicrobial resistance prediction and transmission surveillance. Join us as our expert panellists discuss the application of this technology for TB control.

When: 3rd August 2022
Time: 1200pm-1330pm (AEST)
Register: Here

Speakers

Dr Chris Coulter, QLD MRL – Topic: Introduction TB to Genomics
Dr Chris Coulter is a Microbiologist, the Chair of TB Expert Advisory Group for Tuberculosis in Queensland, and the Director of the Queensland Mycobacterium Reference Laboratory

Dr Norelle Sherry – Topic: Implementation of TB Genomics for Antimicriobial Resistance Prediction and Public Health
Dr Norelle Sherry is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at MDU-PHL and Austin Health, with a special interest in antimicrobial resistance (AMR). She is also a clinician-researcher, investigating the use of genomics for surveillance of antimicrobial resistance in multiple different settings, and translation of genomics from the research lab into clinical use.

Prof Vitali Sintchenko – Topic: Case Studies in TB Genomics
Professor Vitali Sintchenko is a leading public health microbiologist and informatician who conducts research on biosurveillance of communicable diseases. He is a Fellow of the Royal College of Pathologists of Australasia and the Australian College of Health Informatics. As the Director of CIDM-Public Health (a translational research hub funded by NSW Health), he leads a public health and diagnostic microbiology team working toward improving laboratory and epidemiological. investigations of communicable diseases.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 2.6 AUGUST 2017

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 2.6 AUGUST 2017

VOLUME 6.05 – JULY 2021

Research Roundup:

May 2021

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

Enjoy the May edition of your Research Roundup.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

$300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

(Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

“This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

“We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

“The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners.

TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

Open Awards

Thoracic Society Awards

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

Asthma Australia Research Grant and Workshop

Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

  • Aboriginal and Torres Strait Islander People
  • People facing socioeconomic disadvantage
  • People from culturally and linguistically diverse backgrounds.

We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

    Workshop  details

    1. Culturally and linguistically diverse backgrounds

    When: Wednesday 26th May 11-12:30
    Where: Ethnic Community Council Victoria

    1. People facing socioeconomic disadvantage
      Tuesday 25th May 2-3:30pm
    1. Aboriginal and Torres Strait Islander People
      TBC – please register interest

    If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

    2021 Australian Museum Eureka Prizes

    Do you know someone making a difference in their field?

    Entries to the 2021 Australian Museum Eureka Prizes are now open!

    This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

    There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

    If you know an individual or team doing outstanding work, why not encourage them to enter?

    Entries close 7pm AEST Friday 28 May

    VIEW THE FULL PRIZE PROGRAM

    Respirology – Editor’s Choice

    Respirology Issue 26.4 April 2021

    Central airway collapse is related to obesity independent of asthma phenotype

    Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

    DOI: 10.1111/resp.14005

    Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

    Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

    DOI: 10.1111/resp.13978

    Surveys and Research

    SURVEY OF LUNG CANCER CARE IN AUSTRALIA

    We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

    • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
    • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
    • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

    Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

    Thank you for your time.

    Prof Fraser Brims
    Curtin Medical School
    fraser.brims@curtin.edu.au 

    GP PARTICIPATION REQUIRED

    Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

    Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

    All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

    The survey can be accessed by clicking HERE.

    The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

     

    TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

    A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

    This study has now been completed and below is a summary of the findings from this work.

    The top 3 priorities rank by people with PF and caregivers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. What medications can improve lung function in people with PF?
    3. What are the causes of PF?

    The top 3 priorities rank by people with healthcare professionals/researchers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. How can we prevent PF?
    3. What are the causes of PF?

    The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

    (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

    The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

    Yours sincerely,

    Anne Holland
    Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

    TBPod

    The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

    Can you help TSANZ make a difference?

    Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

    1. Making a donation to our Benevolent Fund

    The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
    CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    2. Making a donation to support research

    With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
    Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    3. Establishing a named award

    For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

    4. Leave TSANZ a gift in your will

    If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
    If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

    5. TSANZ New Zealand Branch Incorporated 

    New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
    CLICK HERE to make a donation.

    Thank you for your continued support of TSANZ.

    ATS recap – What’s the latest in pulmonary fibrosis clinical research?

    ATS recap – What’s the latest in pulmonary fibrosis clinical research?

    Event Date: 11th June 2021

    Type: On-Demand Vimeo Video

    Duration: Approx. 1 hour

    This webinar will catch health professionals up on the latest in clinical research in pulmonary fibrosis from the May 2021 ATS conference.

    This year, ATS is a virtual event and with the time difference between Australia-New Zealand the USA, joining sessions live is a challenge! Join us for an ATS wrap up focusing on clinical research in pulmonary fibrosis.

    Chair:

    • A/Prof Tamera Corte

    Presenter:

    • A/Prof Ian Glaspole

    A/Prof Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine. His research focuses on interstitial lung disease, and has included numerous clinical trials exploring treatments for idiopathic pulmonary fibrosis, along with other clinical and laboratory based research, principally focused on improving the symptoms and quality of life of sufferers of these rare lung diseases.

    In collaboration with:
    The Centre for Research Excellence in Pulmonary Fibrosis & Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network

    Registration:

    To register your interest in the on-demand recording, please register below. You will then be sent an e-mail, allowing you to obtain the recording links through Vimeo.

    Category Fee (excl. GST)
    TSANZ Members Free
    Non-members Free

    Require assistance?

    Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

    VOLUME 2.6 AUGUST 2017

    VOLUME 6.04 – MAY 2021

    Research Roundup:

    May 2021

    Welcome Message

    Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

    I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

    We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

    Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

    Enjoy the May edition of your Research Roundup.

    A/Prof Kristin Carson-Chahhoud
    Chair, Research Sub-Committee 

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    $300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

    (Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

    This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

    “This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

    “We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

    Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

    “The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

    The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    TSANZ would like to congratulate the following Award winners.

    TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

    BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

    Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

    TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

    TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

    TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

    Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

    PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

    Open Awards

    Thoracic Society Awards

    TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

    TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

    Asthma Australia Research Grant and Workshop

    Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

    At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

    • Aboriginal and Torres Strait Islander People
    • People facing socioeconomic disadvantage
    • People from culturally and linguistically diverse backgrounds.

    We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

    At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

      Workshop  details

      1. Culturally and linguistically diverse backgrounds

      When: Wednesday 26th May 11-12:30
      Where: Ethnic Community Council Victoria

      1. People facing socioeconomic disadvantage
        Tuesday 25th May 2-3:30pm
      1. Aboriginal and Torres Strait Islander People
        TBC – please register interest

      If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Respirology – Editor’s Choice

      Respirology Issue 26.4 April 2021

      Central airway collapse is related to obesity independent of asthma phenotype

      Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

      DOI: 10.1111/resp.14005

      Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

      Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

      DOI: 10.1111/resp.13978

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      GP PARTICIPATION REQUIRED

      Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

      Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

      All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

      The survey can be accessed by clicking HERE.

      The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

       

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      WHY JOIN US?

      Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

      By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

      X